INTRODUCTION: Primary central nervous system lymphoma is a very rare condition in pediatric patients. CASE REPORT: We describe the case of a 10-year old girl who presented with acute bilateral vision impairment. At the time of presentation, the only positive finding was optic disk swelling, and the brain MRI scan was normal. Seventeen months later, she developed a large-cell non-Hodgkin lymphoma in the brain, with no evidence of neoplasia elsewhere. Immunodeficiencies and Epstein-Barr virus infection could not be demonstrated. The patient was successfully treated with a combination of cyclophosphamide, etoposide, vincristine, methotrexate, and cytarabine, plus intrathecal chemotherapy. Craniospinal irradiation was not used. OUTCOME: The patient's condition is still in remission 68 months after completing the treatment. CONCLUSION: This case is the only non-Hodgkin lymphoma with primary central nervous system location treated in our institution in the last 10 years and represents less than 0.5% of our non-Hodgkin lymphoma series. Due to its rare occurrence, not much is known about the clinical features and treatment outcome of primary central nervous system lymphoma in pediatric patients.
INTRODUCTION:Primary central nervous system lymphoma is a very rare condition in pediatric patients. CASE REPORT: We describe the case of a 10-year old girl who presented with acute bilateral vision impairment. At the time of presentation, the only positive finding was optic disk swelling, and the brain MRI scan was normal. Seventeen months later, she developed a large-cell non-Hodgkin lymphoma in the brain, with no evidence of neoplasia elsewhere. Immunodeficiencies and Epstein-Barr virus infection could not be demonstrated. The patient was successfully treated with a combination of cyclophosphamide, etoposide, vincristine, methotrexate, and cytarabine, plus intrathecal chemotherapy. Craniospinal irradiation was not used. OUTCOME: The patient's condition is still in remission 68 months after completing the treatment. CONCLUSION: This case is the only non-Hodgkin lymphoma with primary central nervous system location treated in our institution in the last 10 years and represents less than 0.5% of our non-Hodgkin lymphoma series. Due to its rare occurrence, not much is known about the clinical features and treatment outcome of primary central nervous system lymphoma in pediatric patients.
Authors: Agnieszka Korfel; Peter Martus; Mohammad R Nowrousian; Dieter K Hossfeld; Heinz Kirchen; Joachim Brücher; Matthias Stelljes; Josef Birkmann; Christian Peschel; Rita Pasold; Lars Fischer; Kristoph Jahnke; Eckhard Thiel Journal: Br J Haematol Date: 2005-01 Impact factor: 6.998
Authors: D F Nelson; K L Martz; H Bonner; J S Nelson; J Newall; H D Kerman; J W Thomson; K J Murray Journal: Int J Radiat Oncol Biol Phys Date: 1992 Impact factor: 7.038
Authors: N Cassoux; H Merle-Beral; V Leblond; B Bodaghi; D Miléa; S Gerber; C Fardeau; I Reux; K H Xuan; C C Chan; P LeHoang Journal: Ocul Immunol Inflamm Date: 2000-12 Impact factor: 3.070
Authors: V Sandor; V Stark-Vancs; D Pearson; R Nussenblat; S M Whitcup; P Brouwers; N Patronas; J Heiss; E Jaffe; M deSmet; D Kohler; R Simon; R Wittes Journal: J Clin Oncol Date: 1998-09 Impact factor: 44.544
Authors: L M Larocca; D Capello; A Rinelli; S Nori; A Antinori; A Gloghini; A Cingolani; A Migliazza; G Saglio; S Cammilleri-Broet; M Raphael; A Carbone; G Gaidano Journal: Blood Date: 1998-08-01 Impact factor: 22.113
Authors: M Krogh-Jensen; F D'Amore; M K Jensen; B E Christensen; K Thorling; M Pedersen; P Johansen; A M Boesen; E Andersen Journal: Leuk Lymphoma Date: 1995-10